Display options
Share it on

Hum Vaccin Immunother. 2021 Jun 03;17(6):1662-1663. doi: 10.1080/21645515.2020.1846400. Epub 2020 Dec 17.

Politicizing public health: the powder keg of rushing COVID-19 vaccines.

Human vaccines & immunotherapeutics

Rupali J Limaye, Molly Sauer, Shaun A Truelove

Affiliations

  1. Departments of International Health, Epidemiology, and Health, Behavior and Society, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  2. Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

PMID: 33327848 PMCID: PMC8115551 DOI: 10.1080/21645515.2020.1846400

Abstract

Vaccine hesitancy is on the rise, as more individuals are delaying or refusing vaccines. This rise in hesitancy has been primarily driven by vaccine safety concerns, even though the vaccine development process is regulated by a robust and rigorous scientific system. Recent data suggest that many individuals would be unwilling to take a COVID-19 vaccine, once one is available. The Trump administration's Operation Warp Speed aims to deliver a vaccine in the near future, even though no American or European COVID-19 vaccine has yet completed Phase 3 trials. The administration has used the emergency use authorization mechanism to fast track therapeutic products through the Food and Drug Administration and has not ruled out using the mechanism to fast track a COVID-19 vaccine. Perceived political pressure to push a COVID-19 vaccine will have a multitude of negative consequences. Not only will it lead to sub-optimal levels of vaccine acceptance toward a COVID-19 vaccine, it will reverse progress made in controlling vaccine preventable disease for years to come.

Keywords: COVID-19 vaccines; vaccine acceptance; vaccine approval; vaccine hesitancy; vaccine safety

References

  1. Vaccine. 2019 Nov 15;37(48):7190-7200 - PubMed
  2. Science. 2020 Jul 3;369(6499):14-15 - PubMed
  3. JAMA Pediatr. 2017 Oct 1;171(10):929-930 - PubMed
  4. Vaccine. 2009 May 26;27(25-26):3295-8 - PubMed
  5. BMJ. 2020 Apr 8;369:m1432 - PubMed
  6. Lancet Infect Dis. 2020 May;20(5):e80-e89 - PubMed
  7. EClinicalMedicine. 2020 Sep;26:100495 - PubMed

Substances

MeSH terms

Publication Types